$12.41
Entrada Therapeutics is a biotechnology business based in the US. Entrada Therapeutics shares (TRDA.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $12.78 – an increase of 4.75% over the previous day. Entrada Therapeutics employs 0 staff and has a trailing 12-month revenue of around $87.2 million.
How to buy shares in Entrada Therapeutics
- Choose a platform. If you're a beginner, our stock trading platform picks below can help you choose.
- Open your account. Provide your personal information and sign up.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: TRDA in this case.
- Research stocks. The platform should provide the latest information available.
- Buy your stocks. Place a market order or limit order with your preferred number of shares. It's that simple.
Our top picks for buying Entrada Therapeutics stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Get $100-$5,000 when you open an account with $5,000 to $1,000,000+
- Earn up to 3% in matching funds on Robinhood IRA contributions
- Earn up to 5.25% interest on uninvested cash
- Get a free stock when you successfully sign up and link your bank account
- Trade fractional shares of stocks, ETFs and Bitcoin
- Invest with as little as $1
- Free to open, no minimum balance required and no commission fees
Is it a good time to buy Entrada Therapeutics stock?
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Share price volatility
Over the last 12 months, Entrada Therapeutics's shares have ranged in value from as little as $10.62 up to $18.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Entrada Therapeutics's is -0.52. This would suggest that Entrada Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Entrada Therapeutics has bucked the trend.
Historical closes compared with the last close of $12.78
1 week (2024-03-10) | 8.67% |
---|---|
1 month (2024-02-15) | -11.13% |
3 months (2023-12-14) | -8.26% |
6 months (2023-09-17) | -10.75% |
1 year (2023-03-16) | -17.71% |
2 years (2022-03-17) | 29.75% |
3 years (2021-03-11) | N/A |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Buy Entrada Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Frequently asked questions
More guides on Finder
-
10 best brokerage account bonuses of 2024
Explore the best bonuses for opening a new brokerage account.
-
11 best trading platforms for beginners 2024
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers of 2024
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
Cash App Investing review 2024
Finder’s Cash App review covers fees, features and feedback to consider before you invest.
-
Methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
E-Trade review 2024
Take advantage of commission-free trading with stocks, ETFs and options with a flexible trading platform.
-
Webull review 2024
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask an Expert